Clinical Trial

Cholecalciferol and Calcifediol Are Both Useful to Improve Vitamin D Serum Levels

Study acronym: VITD
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated November 25, 2025 (before its estimated December 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
Patients with hypovitaminosis D are randomized into three arms of treatment: Group A: Calcifediol 0,266mg each month Group B: Cholecalciferol 25000UI each 15 days Group C: Calcifediol 4 drops per day. Serum levels of vitamin D are dosed after one month of treatment
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2023-11-16; most recent amendment 2025-11-20.
Trial Details
NCT Number NCT06138249
Lead Sponsor Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari
Collaborators: Silvana De Giorgi, Davide Bizzoca, Angela Notarnicola
Conditions Hypovitaminosis D
Enrollment 90 participants
Start Date 2023-07-01
Primary Completion 2025-12-30 (estimated)
Study Completion 2025-12-30 (estimated)
Updated on ClinicalTrials.gov 2025-11-25